| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-06 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |